Clinical trials
Withdrawn Autoimmune Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Boren Hospital | 5 |
| Nanjing Legend Biotech Co. | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 8 |
| Lupus Erythematosus, Systemic | 2 |
| Recurrence | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Immunoglobulin G4-Related Disease | 1 |
| Multiple Sclerosis, Chronic Progressive | 1 |
| Myositis | 1 |
| Scleroderma, Systemic | 1 |
| Thymoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.